论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
益生菌对神经退行性疾病相关症状和系统性炎症的影响:系统综述
Authors Zhu F, Yin S, Wang Y , Zhong Y, Ji Q, Wu J
Received 5 October 2024
Accepted for publication 5 December 2024
Published 10 December 2024 Volume 2024:17 Pages 5941—5958
DOI https://doi.org/10.2147/IJGM.S499406
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Redoy Ranjan
Fengya Zhu,1 Shao Yin,2 Yuan Wang,3 Yue Zhong,1 Qiang Ji,1 Jie Wu2
1Traditional Chinese Medicine Department, Zigong First People’s Hospital, Zigong, People’s Republic of China; 2Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People’s Republic of China; 3Acupuncture and Moxibustion School, Chengdu University of Traditional Chinese Medicine, Chengdu, People’s Republic of China
Correspondence: Jie Wu, Email drwujie@163.com
Abstract: In recent years, probiotics, as a class of biologically active microorganisms, have increasingly attracted attention for their potential in treating neurodegenerative diseases (NDDs). To comprehensively assess the effects of probiotics on clinical symptoms and systemic inflammation regulation in various NDDs, this systematic review conducted a detailed search of the Cochrane Library, Embase, PubMed, and Web of Science databases, ultimately including 22 eligible randomized controlled trials (RCTs), with 4 RCTs for Alzheimer’s Disease (AD), 10 RCTs for Parkinson’s Disease (PD), 2 RCTs for Multiple Sclerosis (MS), and 2 RCTs for Mild Cognitive Impairment (MCI), and intervention durations ranging from 4 to 16 weeks. The comprehensive analysis indicates that probiotics help improve clinical symptoms related to NDDs, including gastrointestinal function, cognitive function, quality of life, and mental health. Additionally, probiotics generally have a positive effect on reducing systemic inflammation and enhancing antioxidant capacity in patients. In conclusion, existing evidence supports the promising potential of probiotics in treating NDDs. However, further large-scale, high-quality studies are needed to explore specific differences in efficacy among various probiotic strains, dosages, and modes of administration. Moreover, considering that lifestyle and dietary habits may modulate the effects of probiotics, these external factors should also be included in research considerations to gain a more comprehensive understanding of the mechanisms and application strategies of probiotics in NDDs treatment.
Keywords: probiotics, neurodegenerative disease, systemic inflammation, systematic review